CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Drug Development Plan Explained: DPP Templates And Examples

  Only 6.7% of Phase 1 drugs reach approval. A well-structured Drug Development Plan (DDP) can meaningfully improve your odds — learn exactly how to build one.

• Vial Adapter Transfer Device Compatibility With Cell Therapies

  Needles and syringes are commonly used to retrieve cell therapies from vials, posing the risk of needle stick injury. Explore the suitability of needle-free polycarbonate transfer devices.

• Navigating The CGT Landscape: Key Takeaways From The FDA's New FAQ

  The FDA's new FAQ on cell and gene therapy offers a roadmap for developers. Review key insights from the document, including the importance of early engagement with the FDA, CMC considerations, and more.

• When To Consider Material And Personnel Airlocks For Downflow Booths

  Strategic use of airlocks in downflow booth design enhances pressure stability and containment. A risk-based approach ensures facility integration meets rigorous safety and compliance standards.

• Building A Scalable Global T Cell Manufacturing Platform

  Achieve scalable T cell manufacturing with automation, standardized workflows, and integrated quality control to enable high-yield production, flexible scheduling, and seamless tech transfer.

• Oligonucleotide Purification And Synthesis

  Examine how a 21‑mer oligo was synthesized and purified through systematic resin screening, method optimization, and successful scale‑up to build reliable, high‑purity chromatography workflows.

• Cytokines For Ex Vivo Cell Culture

  Comparable T cell expansion and function between cytokine sources were demonstrated. Generated CAR-T cells showed robust cytotoxicity and lower exhaustion markers.

• Enabling The Rapid, Reproducible Manufacturing Of TranspoCART Cells

  Learn how an innovative technology streamlines Transpocart cell production, making rapid and consistent manufacturing a reality for cell therapies.

• Unlocking Recruitment Potential In Trial-Naïve Sites

  Site Professional Support enabled this late-phase rheumatoid arthritis study to conduct complex patient visits despite its use of sites that lacked research experience and resources.

• The Need For Adaptive Distribution Partners For Cell And Gene Therapies

  Optimize your commercial strategy by exploring how adaptive distribution models navigate reimbursement challenges and improve patient access. Partner early to align workflows and ensure operational success.